Lupus Clinical Trials in Los Angeles

Showing 141-160 of 171 trials

A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus

NCT02391259

This is a multicenter, randomized, double-blind, placebo-controlled, sequential rising single-dose study in which approximately 56 subjects with SLE will be enrolled in 7 dosing cohorts

Systemic Lupus Erythematosus

Amgen57 participantsStarted Nov 2006

Anniston, Alabama, United States • Phoenix, Arizona, United States • Los Angeles, California, United States +10 more locations

TERMINATEDPhase 2/3< 1 mile

Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis

NCT00430677

The purpose of this clinical research study is to learn if addition of abatacept is safe and improves the effectiveness of treatment of patients with active lupus nephritis who are also taking mycophenolate mofetil (MMF) and corticosteroids.

Systemic Lupus Erythematosus

Bristol-Myers Squibb423 participantsStarted Jun 2007

Birmingham, Alabama, United States • Tucson, Arizona, United States • Los Angeles, California, United States +81 more locations

A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus

Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis

Lupus Trials in Other Cities

Study of Epratuzumab in Systemic Lupus Erythematosus

PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome

PEARL-SC Trial: A Study of the Efficacy, Safety, and Tolerability of A 623 Administration in Subjects With Systemic Lupus Erythematosus

A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus

Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL

Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy

Study of Epratuzumab in Systemic Lupus Erythematosus

A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosus

Efficacy and Tolerability of Armodafinil in Adults With Excessive Sleepiness Associated With Shift Work Disorder

Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder

Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder

Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder

A Safety and Tolerability Study of MEDI-570 in Systemic Lupus Erythematosus

Phase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE)

Oxygen Monitoring of Patients After Surgery on the Hospital General Care Floor

Study of a Sleep Apnea System for the Treatment of Obstructive Sleep Apnea

Reiterative Development and Evaluation Study of OSA Therapy System

Etanercept for the Treatment of Lupus Nephritis

Other Conditions in Los Angeles